Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500106681Phase 4Completed
Phase 4, randomised trial of remimazolam in colorectal cancer (CRC) (2 arms), sponsored by Linyi People's Hospital. Primary endpoint: cerebral oxygen saturation. Started Jul 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500106681.